Top Markets
#1 Status Status +20.04%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.47%
#3 Ontology Gas Ontology Gas +12.46%
#4 GoPlus Security GoPlus Security +12.16%
#5 DMT-NAT DMT-NAT +9.70%
#6 Fake World Assets Fake World Assets +8.34%
#7 Provenance Blockchain Provenance Blockchain +6.75%
#8 Bedrock Bedrock +6.48%
#9 Janction Janction +6.24%
#10 Ontology Ontology +5.54%
Coin of the day
Status Status
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
Classifica tra le azioni #33959
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
Prezzo delle azioni
$1.83
Ultima sincronizzazione: 2026-08-14
Capitalizzazione di mercato
$6.53M
Variazione (1 giorno)
-1.61%
Variazione (1 anno)
-85.57%
Paese
US
Scambia Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Categoria

Healthcare
Il prezzo CVKD con la capitalizzazione del mercato della B
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock
CVKD
$1.83
Capitalizzazione di mercato di Cadrenal Therapeutics, Inc. Common Stock(CVKD)
Capitalizzazione di mercato: $6.53M
A partire dal August 2026, Cadrenal Therapeutics, Inc. Common Stock ha una capitalizzazione di mercato pari a $6.53M. Questo rende Cadrenal Therapeutics, Inc. Common Stock la 33959th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Cadrenal Therapeutics, Inc. Common Stock dal 2023 al 2026
CVKD in paragone con la classifica dei più popolari stocks
Il prezzo per CVKD Attivo B Capitalizzazione del mercato a B Risultati
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock
$1,528,108 $6.53M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.452T +83,503,043.85%
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock
$1,258,511 $6.53M
Apple Inc. Apple Inc.
AAPL
$4.490T +68,770,974.14%
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock
$1,166,684 $6.53M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +63,753,110.65%
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock
$1,030,444 $6.53M
Microsoft Corporation Microsoft Corporation
MSFT
$3.676T +56,308,337.14%
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock
$794,075 $6.53M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.833T +43,391,995.61%